Viking Therapeutics (VKTX) released new clinical trial data on Sunday for its ... In a phase 2 trial of the same drug ...
An injection pen of Zepbound, Eli Lilly’s weight-loss drug, is displayed in New York City, December 11, 2023. [Photo: ...
Ozempic, Wegovy or Mounjaro: the battle of the weight-loss injections - As weight-loss injections emerge as key players in ...
Losing more than 8% of weight in less than a month. This is the promise of a pill under experimentation in the laboratories ...
“I’m playing doctor,” Bookless said, describing her foray into the world of do-it-yourself GLP-1 medication, injections ...
LONDON, Nov 7 — Novo Nordisk said the side effects in trials so far for its experimental obesity drug CagriSema were similar ...
Wall Street analysts were impressed by data showing competitive rates of weight loss for Viking’s therapy, but shares in the ...
Amgen stock rose moderately Thursday after Chief Financial Officer Peter Griffith said the biotech is "laser-focused" on developing its obesity treatment, MariTide.Please watch the video at Investors.